FT : Office Depot rejects $2.1bn takeover bid from rival Staples

Office Depot rejects $2.1bn takeover bid from rival Staples
Company says latest proposal is not in shareholders’ interests but is open to negotiations

Office Depot has rebuffed a $2.1bn takeover bid from its larger rival Staples but said it was open to negotiating a deal, as the two largest US bricks-and-mortar stationery retailers make a third attempt to combine, according to people briefed on the matter.

In a letter sent to Staples’ board, ODP said that the proposed takeover bid would not be in the best interest of its shareholders.

Staples, which is controlled by US private equity group Sycamore, had offered on January 11 to pay $40 per share for ODP, a more than 60 per cent premium to ODP’s average closing share price during the 90 days prior to the bid.

The unsolicited bid from Staples marks the latest attempt by the US office-supply chain to acquire its smaller rival, four years after a federal judge blocked what was then a $6.3bn bid for ODP on the basis that it would hurt competition. A merger was also blocked in 1997, when they proposed to create “Staples the Office Depot”.

Since the last merger attempt both retailers have struggled to compete with the likes of Amazon and Walmart, which have won market share with regular and corporate customers. 

While office suppliers have held up better than other retailers due to a shift towards working from home, the pandemic has exacerbated challenges faced by the retail sector as lockdowns dent sales. 

Staples is convinced the changing nature of the market will be sufficient to secure regulatory backing and push forward with a deal that will allow it to make significant cost savings. 

ODP downplayed its rival’s projections, saying in its letter that the cost savings generated by the proposed merger with Staples could be obtained by staying independent.

Staples said last week that it would consider increasing its offer for ODP if the company agreed to sell some of its assets, including CompuCom, a business ODP acquired in late 2017 for $1bn.

FT : MGM walks away from Entain after rejection of £8bn offer

MGM walks away from Entain after rejection of £8bn offer
Shares in UK-based owner of Ladbrokes and Coral fall sharply

MGM has said it will not make a firm offer to buy the UK gambling company Entain, two weeks after its £8bn proposed takeover bid was rejected by the target’s board.

“After careful consideration and having reflected on the limited recent engagement between the respective companies regarding MGM’s rejected all stock proposal . . . [MGM] does not intend to submit a revised proposal,” the company said on Tuesday. 

The share price of Entain, which owns the Ladbrokes and Coral chains in the UK, fell sharply on the news and was down 16 per cent in lunchtime trading in London.

MGM’s initial proposal, which followed several overtures in November, was rebuffed by the board of Entain, which argued that it “significantly undervalued” the business. 

The news also follows the shock departure of Entain’s chief executive last week.

The two companies run a 50/50 joint venture together in the US to tap into the booming sports betting and online gaming market, which analysts estimate could reach annual revenues of $20bn or more by 2025.

Barry Diller, whose holding company IAC is MGM’s largest shareholder, told the Financial Times in an interview this month that he was “sceptical” that the deal could be done, but that MGM would be in a “leadership position whatever” in the online gaming market.

MGM said in Tuesday’s statement that it was still “committed to being a premier global omnichannel gaming and entertainment company, and will maintain a disciplined framework while evaluating a range of compelling strategic opportunities.”

NY Post : On Park Avenue, a $1 billion tower is set to soar

On Park Avenue, a $1 billion tower is set to soar

It’s stepping-out time for 425 Park Ave., the 47-story, Norman Foster-designed office tower crowned by a trident of sky-piercing, 136-feet-tall illuminated fins.

More than five years since the groundbreaking, L&L Holding Co.’s $1 billion gamble on Park Avenue’s future just received its temporary certificate of occupancy from the Department of Buildings. It allows Ken Griffin’s Citadel Enterprises to start moving in as soon as it completes its high-tech build-out.

The hedge fund has leased 331,800 square feet of the tower’s 690,000 square feet of offices, at some of the highest office rent ever recorded.

Of course, 2022 is not 2016, when Citadel signed the lease. As the property world anxiously watches the project for signs of which way the pandemic-crippled leasing market’s headed, developer David W. Levinson revealed that:

  • Prospective tenants scoping out the remaining 358,000 square feet may receive a “meaningful discount” over Citadel’s, much-reported eye-popping rent. The hedge fund’s top two floors went for an office-market record of $300-plus per square foot four years ago and its space on 14 other floors has been estimated at plus-or-minus $200 per square foot.
  • Levinson expects to see “in excess of 100,000” additional square feet to be leased in 2021.
  • Construction is delayed on the ground-floor restaurant by superchef Daniel Humm, named Four Twenty-Five, but will likely begin early this year.

Aggressively expanding L&L developed the striking edifice, distinguished by two graceful façade setbacks, with co-equity partner and co-developer Tokyu Land Corp. and co-managing partner BentallGreenOak. Its unique features include two “diagrid” floors with ceilings up to 38 feet; a 45-foot-high lobby; elevators that run at 1,200 feet per minute; and a double-height 26th floor club floor for tenants only. It will be the city’s first WELL-certified building for numerous health, wellness and environment-friendly features.

Rising to 897 feet, it isn’t as monumental as 1,401-feet-tall One Vanderbilt near Grand Central Terminal or other new towers in the Hudson Yards district. But it’s a bellwether for Park Avenue, which Levinson calls “the grand boulevard of commerce in America.”

After losing some large tenants a few years ago such as Wells Fargo, the corridor has rebounded with JPMorgan Chase’s decision to create a new headquarters tower; major upgrades at 280 and 299 Park Ave.; and a recent major lease for Raymond James at 320 Park. CBRE recently estimated the avenue’s space availability at slightly more than 12 percent, on par with Midtown.

All eyes now are on 425 Park, the first full-block tower on the avenue in a half-century. Levinson acknowledged, “This is clearly not a good market. We had to adjust pricing because the market tells us to do that. It’s the kind of market, whether at 425 Park or other high-end buildings, the smartest people can take advantage of it. They’d pay more of a premium when the market becomes healthier.”

He said the discount — which he wouldn’t quantify in percentage terms — won’t last forever. “We’ll increase prices again in late 2021 or 2022. Some guys will get really good deals until then.” Several such “guys,” mainly financial firms, are in “very serious negotiations,” he said.

The restaurant delay was by design, Levinson said. “We want better timing. We don’t want to have a restaurant when nobody can go to it,” he said of the open-ended ban on indoor dining in the city. “Daniel [Humm] and I speak a couple of times a week. We’re very excited. We want to finish it when people can actually go there.” It should be open late this year or early in 2022.

FiDi foodies rejoice
Urbanspace is coming to the rescue of the anemic FiDi eating scene. The expanding food hall and marketplace outfit is launching its sixth city location at 100 Pearl St., a GFP Real Estate-owned office tower between Coenties Slip and Hanover Square.

It’s a stroke of faith in the Wall Street area, where office buildings remain largely empty and some rental-apartment residents have fled.

The new culinary complex covers 14,722 square feet, much of it inside a 21-foot-high through-block walkway between Water and Pearl streets. To make room for it, GFP had to re-imagine its ground-floor public and private spaces — including the adaptation of the arcade for retail use. Such changes were encouraged by a 2017 rezoning measure intended to bring more life into little-used plazas and arcades in the Water Street corridor.

The new Urbanspace will have 16 “curated” high-quality food vendors. The company’s most recent lease was for the Zero Irving project near Union Square. Urbanspace president Eldon Scott said that after “a devastating year for restaurants, our food halls offer a supportive space” for chefs and the communities they serve.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • NOV -7.4%, FMC -3.4%, BAC -1.6%, STT -1.4%

M&A news:

  • LITE -8.4% (Lumentum (LITE) and Coherent (COHR) to merge)

Other news:

  • PRPH -23.6% (announces the pricing of an underwritten public offering of 3,000,000 shares of common stock at an offering price of $12.50/share)
  • BHVN -13.5% (Provides Update On Phase 2/3 Trial And Alzheimer's Disease Program)
  • SENS -5.1% (enters registered offering to sell 40 mln shares of its common stock at $1.25 per share)
  • KERN -2.2% (files for 6,119,091 share common stock offering by selling shareholders)

Analyst comments:

  • DISCA -2% (downgraded to Underweight from Equal Weight at Barclays)
  • VIAC -1.1% (downgraded to Underweight from Overweight at Barclays)
  • CERN -1% (downgraded to Underperform from Buy at BofA Securities)
  • AKR -0.7% (downgraded to Neutral from Buy at BofA Securities)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • TRQ +6.4%, LOGI +3.7%, HAL +2.8%, GS +2.8%, FSM +2.1%, KFRC +1.9%, TROX +1.3%, SMTS +1.1%, CMA +0.7%

M&A news:

  • COHR +34.3% (Lumentum (LITE) and Coherent (COHR) to merge)

Other news:

  • ACRS +68.9% (announced positive preliminary topline results from a 12-week, Phase 2a trial of ATI-450 in subjects with moderate to severe rheumatoid arthritis)
  • TRXC +36.7% (receives CE mark for machine vision system in robotic surgery)
  • GRTS +27.7% (advances second generation COVID-19 vaccine "coral" program with support from NIAID; program has potential to protect against mutant variants of SARS-CoV-2)
  • TSHA +17.9% (receives rare pediatric disease and orphan drug designations for TSHA-105 for the treatment of epilepsy caused by SLC13A5 Deficiency)
  • VRCA +13.9% (present data from post-hoc pooled analyses of the pivotal Phase 3 CAMP trials evaluating the safety and efficacy of VP-102 in molluscum contagiosum (molluscum) in specific body regions at each visit)
  • DTIL +11.2% (FDA has accepted the IND application for PBCAR19B for patients with relapsed/refractory (R/R) Non-Hodgkin Lymphoma)
  • ARAY +9.7% (announces that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8% had local disease control seven years after receiving once-daily accelerated partial breast irradiation delivered with the TomoTherapy System)
  • SSP +9.6% (Berkshire Hathaway (BRK.B) reports 24.9% passive stake in 13G filing)
  • MCRB +8.1% (will present new data from its SER-109 Phase 3 ECOSPOR III clinical study that confirm the intended pharmacological properties of this investigational microbiome therapeutic for recurrent C. difficile infection)
  • CYAD +7.9% (Presents Data Update from Phase 1 alloSHRINK Trial for CYAD-101)
  • MTCR +7.1% (announces FDA fast track designation for MET642 as a treatment of NASH)
  • GRFS +6.8% (begins clinical trial of a new treatment that would provide immediate immunity against COVID-19)
  • WU +6.2% (Western Union and Walmart (WMT) enter agreement to offer western union money transfers at Walmart)
  • MRUS +5.5% (Eli Lilly and Merus NV (MRUS) announce collaboration to discover novel T-Cell re-directing bispecific antibodies)
  • CTSO +4.9% (announces approval of CytoSorb in Korea in collaboration with partner Fresenius Medical Care)
  • BEAM +4.4% (announces $260 million common stock investment from multiple investors)
  • SKYW +4% (receives half of $233 mln in PSP funds)
  • ALLT +3.8% (Tier-1 Telecom service provider in Europe selects Allot HomeSecure and BusinessSecure to provide cyber-protection to consumers and SMbs)
  • CRSP +3.6% (files for $600 mln common stock offering)
  • PRLB +3.3% (entered into a definitive agreement to acquire 3D Hubs)
  • SOL +3.2% (files for $250 mln mixed securities shelf offering)
  • AZN +2.7% (ENHERTU (fam-trastuzumab deruxtecan-nxki) Approved in the US for the Treatment of Patients with Previously Treated HER2-Positive Advanced Gastric Cancer)
  • EQNR +2.6% (has been awarded 17 new production licenses by Norway's Ministry of Petroleum and Energy)
  • APT +2% (Biden says he will sign executive order requiring masks on federal property, planes trains, wherever he has authority to do so)
  • PAAS +1.9% (reports FY20 silver production; provides FY21 outlook) GM +1.8% (to invest nearly $800 million to convert CAMI into Canada's first large-scale commercial electric vehicle manufacturing plant)
  • LLY +1.8% (Eli Lilly and Merus NV (MRUS) announce collaboration to discover novel T-Cell re-directing bispecific antibodies)
  • AGIO +1.7% (Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO)
  • ORTX +1.7% (to extend the company's commercial reach in the Middle East and Turkey through exclusive agreements with GenPharm Services and GEN)

Analyst comments:

  • BLDP +8.4% (initiated with an Outperform at BMO Capital Markets)
  • ETM +7.5% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • CLF +4.2% (upgraded to Outperform from Neutral at Exane BNP Paribas)
  • PAGS +3.3% (upgraded to Buy from Neutral at Goldman)
  • DRI +3.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • SNDR +3.2% (upgraded to Outperform from Neutral at Credit Suisse)
  • ITW +2.9% (upgraded to Neutral from Sell at Goldman)
  • LI +2.5% (initiated with a Buy at Jefferies)
  • EMR +2.2% (upgraded to Buy from Neutral at Goldman)
  • ROKU +2.2% (initiated with an Overweight at JP Morgan)
  • GILD +2.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • FB +2% (upgraded to Outperform from Market Perform at BMO Capital Markets)
  • AXP +1.9% (upgraded to Overweight from Underweight at JP Morgan)
  • NDAQ +1.4% (upgraded to Buy from Neutral at UBS)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • GRTS +45.1%, COHR +35%, MTCR +14%, SSP +9.2%, CYAD +7.9%, GRFS +7.6%, MRUS +7.3%, WU +7.2%, TRQ +5.9%, ALLT +4.9%, LOGI +4.4%, SOL +4%, SKYW +4%, FSM +4%, GRCL +3.6%, CRSP +3.5%, AZN +3%, HAL +2.7%, EQNR +2.4%, APT +2%, GM +1.8%, LLY +1.5%, DAL +1.1%, SMTS +1.1%, LUV +1%, LMT +0.8%, RIO +0.8%, BEAM +0.8%
  • Gapping down:
    • PRPH -20.4%, BHVN -10.5%, AGIO -7.3%, LITE -6.9%, SENS -5.7%, KERN -3%, GCI -1.8%, NGL -1.4%, TROX -1.4%, CMA -0.5%

FT : Hammerson collects less than half its rent from retailers

Hammerson collects less than half its rent from retailers
Bullring owner receives 41% of quarterly payments as shopping centre tenants suffer

Hammerson has collected less than half the rent it is owed this quarter, adding to pressure on the shopping centre owner, which has been severely hit by coronavirus.

Hammerson has struggled in the past year as the pandemic has ravaged the UK retail sector and heaped more pain on to shopping centres, which were already suffering from the loss of customers to online rivals before the pandemic.

The company, which owns a number of the UK’s most recognisable centres, including the Bullring shopping centre in Birmingham and Brent Cross in London, said on Tuesday it had received 41 per cent of the rent owed for the first three months of the year, which tenants typically pay in advance.

The landlord has agreed to defer £12.9m in payments to a later date, and has collected £19.8m of the remaining £48.6m it was due for the period.

Restrictions imposed to contain the virus have forced all but essential shops in its centres to close, and the company’s unpaid rent bill has ballooned thanks to the pandemic, with £72.5m in arrears built up since the start of 2020. Only a quarter of Hammerson’s UK tenants are permitted to open, and its French shopping centres are subject to a 6pm curfew.

“Market conditions have remained challenging since our last update in October, with national lockdowns introduced in the UK, Ireland, and France in November, and significant restrictions in place across the portfolio through December,” said the company.

Hammerson has repaid £812m of debt in recent months, using the windfall from a £552m rights issue and the sale of a 50 per cent stake in its European shopping outlets business VIA Outlets for €307m.

But Sam King, an analyst at Stifel, warned that the value of Hammerson’s portfolio of centres was likely to fall further.

As a result, said Mr King in a note, “we see limited upside to the shares in the short term, given the challenges that need to be overcome in regard to rent collection, the balance sheet and adopting a new leasing model, which will result in more risk sharing with tenants”.

The company’s largest rival in the UK, Intu, collapsed into administration in June last year, and efforts to sell off its portfolio of shopping centres have been hampered by a lack of willing buyers.

The Trafford Centre in Manchester, considered the jewel in Intu’s crown, is now owned by the Canada Pension Plan Investment Board, a key lender to Intu, after a sales process failed to attract any viable bids.

Shares in Hammerson were up about 2 per cent in early trading to 23p. Over the past 12 months shares in the company have lost 80 per cent of their value.

Hammerson is on the hunt for a new chief financial officer after James Lenton resigned last week, having been at the company for a little over a year.